Editas Medicine Company Profile

Aggregated data from the web about Editas Medicine

Company Name	Editas Medicine
Website	https://www.editasmedicine.com
Snippet	At Editas Medicine, we are pioneering the possible. Our mission and commitment is to harness the power and potential of CRISPR gene editing to develop a robust pipeline of medicines for people living with serious diseases around the world.
Type	Public
Founded	2013
Website	www.editasmedicine.com
Industry	Biotechnology, Genome engineering, Pharmaceutical
Traded as	NASDAQ: EDITRussell 2000 Component
Key people	Cynthia Collins (President and CEO) James C. Mullen (Chairman)
Headquarters	Cambridge, Massachusetts, United States
Total assets	US$508,885,000 (2019)
Total equity	US$262,437,000 (2019)
Number of employees	208[1] (2020)

Editas Medicine is part of the United States company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.